DrugPatentWatch Database Preview
ZALTRAP Drug Profile
Summary for Tradename: ZALTRAP
| Patents: | 8 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for ZALTRAP |
Recent Clinical Trials for ZALTRAP
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Kapil Kapoor | Phase 2 |
| Barts & The London NHS Trust | Phase 2 |
| Rabin Medical Center | Phase 1/Phase 2 |
Patent Text Search: US Patents for ZALTRAP
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | ZALTRAP | ziv-aflibercept | INJECTABLE; INJECTION | 125418 | 001 | 2012-08-03 | Start Trial | The Rockefeller University (New York, NY) | 2032-10-31 | RX | search | |
| Sanofi Aventis Us | ZALTRAP | ziv-aflibercept | INJECTABLE; INJECTION | 125418 | 001 | 2012-08-03 | Start Trial | HANGZHOU DAC BIOTECH CO., LTD. (Hangzhou, CN) | 2035-07-15 | RX | search | |
| Sanofi Aventis Us | ZALTRAP | ziv-aflibercept | INJECTABLE; INJECTION | 125418 | 001 | 2012-08-03 | Start Trial | BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS (GR) | 2035-07-08 | RX | search | |
| Sanofi Aventis Us | ZALTRAP | ziv-aflibercept | INJECTABLE; INJECTION | 125418 | 001 | 2012-08-03 | Start Trial | HANGZHOU DAC BIOTECH CO., LTD. (Hangzhou, CN) | 2035-07-15 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for ZALTRAP
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 104918659 | Start Trial |
| Canada | 2890045 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2017082629 | Start Trial |
| Japan | 2018536711 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
